Bring recent lab results if available, and prepare to discuss your weight loss goals honestly
How does Flow Wellness approach GLP-1 microdosing
Yeswe can assess glutathione status through functional lab testing, along with markers for liver function, oxidative stress, and detox capacity
Beyond T2D and weight management in individuals with overweight or obesity, GLP-1 receptor agonists are approved for metabolic dysfunction associated steatohepatitis in people with moderate or advanced fibrosis, obstructive sleep apnea in obese adults, reduction of major adverse cardiovascular events in adults with T2D and cardiovascular disease (CVD), and slowing progression of chronic kidney disease and cardiovascular mortality in adults with both chronic kidney disease and T2D
States With Limited Type 2 Diabetes GLP-1 Coverage A smaller subset of the states mentioned above with no coverage for obesity-indicated GLP-1sincluding the District of Columbia, Florida, and New Jerseyalso limits coverage for Type 2 diabetes-indicated GLP-1s
Do not consume other products containing caffeine at the same time (e.g.: other food supplements, energy drinks, coffee)
